350 related articles for article (PubMed ID: 21495928)
1. Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.
Ness KK; Armenian SH; Kadan-Lottick N; Gurney JG
Expert Rev Hematol; 2011 Apr; 4(2):185-97. PubMed ID: 21495928
[TBL] [Abstract][Full Text] [Related]
2. The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors.
Marcoux S; Drouin S; Laverdière C; Alos N; Andelfinger GU; Bertout L; Curnier D; Friedrich MG; Kritikou EA; Lefebvre G; Levy E; Lippé S; Marcil V; Raboisson MJ; Rauch F; Robaey P; Samoilenko M; Séguin C; Sultan S; Krajinovic M; Sinnett D
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27917589
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.
Bryant J; Picot J; Levitt G; Sullivan I; Baxter L; Clegg A
Health Technol Assess; 2007 Jul; 11(27):iii, ix-x, 1-84. PubMed ID: 17610809
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes in survivors of childhood acute lymphoblastic leukemia.
Nathan PC; Wasilewski-Masker K; Janzen LA
Hematol Oncol Clin North Am; 2009 Oct; 23(5):1065-82, vi-vii. PubMed ID: 19825453
[TBL] [Abstract][Full Text] [Related]
5. Late effects among survivors of leukemia during childhood and adolescence.
Bhatia S
Blood Cells Mol Dis; 2003; 31(1):84-92. PubMed ID: 12850490
[TBL] [Abstract][Full Text] [Related]
6. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.
Sorensen K; Levitt G; Bull C; Chessells J; Sullivan I
J Clin Oncol; 1997 Jan; 15(1):61-8. PubMed ID: 8996125
[TBL] [Abstract][Full Text] [Related]
7. Myocardial 2D Strain During Long-Term (>5 Years) Follow-Up of Childhood Survivors of Acute Lymphoblastic Leukemia Treated With Anthracyclines.
Pourier MS; Mavinkurve-Groothuis AMC; Dull MM; Weijers G; Loonen J; Bellersen L; de Korte CL; Kapusta L
Am J Cardiol; 2020 Jul; 127():163-168. PubMed ID: 32444028
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and chronic health conditions in childhood acute leukaemia survivors.
Corella Aznar EG; Ayerza Casas A; Carboné Bañeres A; Calvo Escribano MÁC; Labarta Aizpún JI; Samper Villagrasa P
Med Clin (Barc); 2019 Mar; 152(5):167-173. PubMed ID: 30017209
[TBL] [Abstract][Full Text] [Related]
9. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
van Dalen EC; Raphaël MF; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2014 Sep; (9):CD006647. PubMed ID: 25188452
[TBL] [Abstract][Full Text] [Related]
10. Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood.
Prestor VV; Rakovec P; Kozelj M; Jereb B
Pediatr Hematol Oncol; 2000; 17(7):527-40. PubMed ID: 11033728
[TBL] [Abstract][Full Text] [Related]
11. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL).
Steffens M; Beauloye V; Brichard B; Robert A; Alexopoulou O; Vermylen Ch; Maiter D
Clin Endocrinol (Oxf); 2008 Nov; 69(5):819-27. PubMed ID: 18429947
[TBL] [Abstract][Full Text] [Related]
12. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.
Follin C; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2006 May; 91(5):1872-5. PubMed ID: 16522695
[TBL] [Abstract][Full Text] [Related]
13. [Sequelae after successful treatment of ALL in childhood and adolescence: follow-up is precautionary].
Langer T
Pharm Unserer Zeit; 2012 May; 41(3):234-8. PubMed ID: 22844671
[No Abstract] [Full Text] [Related]
14. Long-Term Effect of Cranial Radiotherapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors.
Follin C; Erfurth EM
Curr Treat Options Oncol; 2016 Sep; 17(9):50. PubMed ID: 27476159
[TBL] [Abstract][Full Text] [Related]
15. Cardiac autonomic dysfunction in survivors of childhood acute lymphoblastic leukemia: The St. Jude Lifetime Cohort Study.
Christoffersen L; Gibson TM; Pui CH; Joshi V; Partin RE; Green DM; Lanctot JQ; Howell CR; Mulrooney DA; Armstrong GT; Robison LL; Hudson MM; Ness KK
Pediatr Blood Cancer; 2020 Jul; 67(7):e28388. PubMed ID: 32383821
[TBL] [Abstract][Full Text] [Related]
16. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
[TBL] [Abstract][Full Text] [Related]
17. Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group.
Rammeloo LA; Postma A; Sobotka-Plojhar MA; Bink-Boelkens MT; Berg A; Veerman AJ; Kamps WA
Med Pediatr Oncol; 2000 Jul; 35(1):13-9. PubMed ID: 10881002
[TBL] [Abstract][Full Text] [Related]
18. Late effects of childhood acute leukemia and its treatment.
Yamamoto M; Fukunaga Y; Tsukimoto I; Bessho F; Akatsuka J; Hosoya R; Nakazawa S; Sakurai M; Ueda K; Miyazaki S
Acta Paediatr Jpn; 1991 Aug; 33(4):573-88. PubMed ID: 1792918
[TBL] [Abstract][Full Text] [Related]
19. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
van Dalen EC; Raphaël MF; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2011 Jan; (1):CD006647. PubMed ID: 21249679
[TBL] [Abstract][Full Text] [Related]
20. Providing primary care for long-term survivors of childhood acute lymphoblastic leukemia.
Oeffinger KC; Eshelman DA; Tomlinson GE; Tolle M; Schneider GW
J Fam Pract; 2000 Dec; 49(12):1133-46. PubMed ID: 11132063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
